FBLG
FibroBiologics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.93
−3.99%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- -$0.63
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- -$0.66
- EPS estimate
- -$0.93
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +15.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | -$0.93 | -$0.66 | Beat 29.03% | — |
| Apr 30, 2026 | -$1.26 | -$1.33 | Miss -5.56% | — |
| Feb 24, 2026 | -$0.09 | -$0.03 | Beat 66.67% | — |
| Oct 31, 2025 | -$0.10 | -$0.13 | Miss -30.00% | — |
| Jul 31, 2025 | -$0.11 | -$0.12 | Miss -9.09% | — |
| Mar 31, 2025 | -$0.10 | -$0.09 | Beat 10.00% | — |
| Dec 30, 2023 | — | -$0.34 | — | — |
| Jun 29, 2023 | — | -$0.07 | — | — |
| Jun 30, 2022 | — | -$0.04 | — | — |
| Mar 31, 2022 | — | -$0.04 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026